World leading approach to protect babies from RSV

10 November 2024 - Australian mums and their newborn babies will have free access to the best and most comprehensive ...

Read more →

Moderna receives Health Canada approval for RSV vaccine for adults aged 60 years and older

8 November 2024 - mRESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only ...

Read more →

Expanded age indication for GSK's Arexvy, the first respiratory syncytial virus vaccine approved in Canada for adults aged 50-59 at increased risk

5 November 2024 - Clinical development program continues to evaluate safety and immunogenicity in adults aged 18-49 at increased risk ...

Read more →

NS parents dismayed by lack of access to new RSV vaccines for infants

3 November 2024 - Officials say there is no universally available, publicly funded RSV vaccine program for newborns in Nova Scotia. ...

Read more →

US FDA approves Pfizer’s RSV vaccine Abrysvo for adults aged 18 to 59 at increased risk for disease

22 October 2024 - Approval based on data from pivotal Phase 3 trial in adults at increased risk of lower ...

Read more →

PHARMAC seeking bids from suppliers for COVID-19 vaccines

17 October 2024 - PHARMAC is seeking bids from pharmaceutical suppliers of COVID-19 vaccines. ...

Read more →

Valneva and LimmaTech awarded FDA fast track designation for tetravalent Shigella vaccine candidate S4V

16 October 2024 - Valneva and LimmaTech Biologics announced today that the US FDA has granted fast track designation to ...

Read more →

Novavax's updated 2024-2025 Nuvaxovid COVID-19 vaccine receives authorisation in the EU

9 October 2024 - Novavax today announced that the European Commission granted marketing authorisation for Novavax's updated 2024-2025 Nuvaxovid COVID-19 vaccine ...

Read more →

MHRA approves Comirnaty KP.2 COVID-19 vaccine for adults

10 October 2024 - The MHRA has today approved an adapted Pfizer/BioNTech COVID-19 vaccine (Comirnaty) that targets the KP.2 COVID-19 sub-variant ...

Read more →

The FDA approved a self-administered nasal spray for the flu. Here’s how it compares to the traditional flu shot.

6 October 2024 - The US FDA recently approved FluMist as a self or caregiver-administered nasal spray flu vaccine to prevent ...

Read more →

Pfizer Canada and BioNTech receive Health Canada approval of Omicron KP.2 variant adapted COVID-19 vaccine

24 September 2024 - Omicron KP.2 variant adapted vaccine Comirnaty is now authorised in Canada for individuals 6 months of age ...

Read more →

Moderna receives Health Canada approval for updated COVID-19 vaccine targeting KP.2 variant of SARS-COV-2 for ages six months and older

17 September 2024 - Spikevax is the first updated COVID-19 vaccine authorised in Canada for 2024-2025, offering a timely solution to ...

Read more →

GSK’s Menveo meningococcal vaccine in new single-vial, fully liquid presentation receives positive European CHMP opinion

24 September 2024 - Marketing authorisation in EU expected by November 2024. ...

Read more →

More Australians now eligible for free shingles vaccination

22 September 2024 - The Albanese Government is expanding one of the most comprehensive and widely available shingles vaccination programs ...

Read more →

New COVID-19 vaccine by Moderna approved by Health Canada

17 September 2024 - Health Canada has approved an updated version of Moderna’s COVID-19 vaccine, a decision that means some ...

Read more →